
China Resources Boya Bio-pharmaceutical Group Investor Relations Material
Latest events

Q1 2025
25 Apr, 2025

H2 2024
19 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from China Resources Boya Bio-pharmaceutical Group Co Ltd
Access all reports
China Resources Boya Bio-pharmaceutical Group Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and distribution of plasma-derived biopharmaceutical products. The company's offerings include a range of products for immune system support, blood coagulation, and other therapeutic uses. China Resources Boya operates production facilities and leverages advanced bioprocessing technologies to ensure high standards in the manufacturing and quality control of its products. In addition to its focus on healthcare needs, the company also engages in initiatives aimed at expanding its biopharmaceutical pipeline. China Resources Boya Bio-pharmaceutical Group is headquartered in Chengdu, China, and its shares are listed on the Shenzhen Stock Exchange.
Key slides for China Resources Boya Bio-pharmaceutical Group Co Ltd


H1 2024
China Resources Boya Bio-pharmaceutical Group Co Ltd


H1 2024
China Resources Boya Bio-pharmaceutical Group Co Ltd
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
300294
Country
🇨🇳 China